PEEP vs. ZEEP in Out-of-Hospital-Cardiac-Arrest

NCT ID: NCT06836830

Last Updated: 2025-08-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

600 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-06-01

Study Completion Date

2026-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Out-of-hospital cardiac arrest (OHCA) remains a major cause of mortality, with low survival probabilities to hospital discharge. Despite the frequent use of airway management and mechanical ventilation during resuscitation, there is limited evidence regarding the optimal ventilation strategy to improve oxygen delivery and patient outcomes. The present study aims to investigate the effects of positive-end-expiratory-pressure (PEEP) set at 5 mbar compared to zero-end-expiratory-pressure (ZEEP) on the return of spontaneous-circulation (ROSC) in adult patients with OHCA.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a prospective, multicenter, cluster-randomized controlled trial conducted across emergency medical services (EMS) in the regions of Guetersloh, Minden-Luebbecke and Osnabrueck. Adult patients (\>= 18 years) with OHCA who are undergoing mechanical ventilation through an airway device will be enrolled. The clusters (regional district) will be randomized into two groups: one group will receive ventilation with PEEP set at 5 mbar (intervention group), while the other group will receive ventilation with ZEEP (control group). The study's primary endpoint is the rate of ROSC. Secondary endpoints include rate of re-arrest, death during pre-hospital care phase, hospital admission during ongoing resuscitation, hospital admission with spontaneous circulation, peripheral oxygen saturation and end tidal CO2 at hospital admission.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ventilation Therapy PEEP, Occult CPR Cardiac Arrest (CA)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PEEP

PEEP Group (Intervention Group): Patients will receive mechanical ventilation with end-expiratory-pressure set at 5 mbar (PEEP).

Group Type EXPERIMENTAL

PEEP 5 mbar

Intervention Type PROCEDURE

Positiv-End-Expiratory Pressure

ZEEP

ZEEP Group (Control Group): Patients will receive mechanical ventilation with end-expiratory-pressure set at 0 mbar (ZEEP).

Group Type EXPERIMENTAL

ZEEP 0 mbar

Intervention Type PROCEDURE

Zero-End-Expiratory Pressure

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

PEEP 5 mbar

Positiv-End-Expiratory Pressure

Intervention Type PROCEDURE

ZEEP 0 mbar

Zero-End-Expiratory Pressure

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults \>= 18 years
* non-traumatic OHCA
* mechanical ventilation via airway device

Exclusion Criteria

* Patients \< 18 years,
* traumatic cause of OHCA,
* no cardiac arrest, withholding of resuscitation (e.g. Do-Not-Resuscitate orders)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Muehlenkreiskliniken, MKK

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Gerrit Jansen

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Emergency Medical Services

Gütersloh, North Rhine-Westphalia, Germany

Site Status RECRUITING

JWK Minden

Minden, North Rhine-Westphalia, Germany

Site Status RECRUITING

Emergency Medical Services

Osnabrück, , Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Gerrit Jansen, PD Dr. med.

Role: CONTACT

+49 571-790-54401

Jochen Hinkelbein, Prof. Dr. med.

Role: CONTACT

+49 571-790-54401

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Julia Johanna Grannemann, MD, MSc

Role: primary

+491706765460

Bernd Strickmann, MD

Role: backup

Jochen Hinkelbein, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024-1148

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.